Premium
Aggregation of features of the metabolic syndrome is associated with increased prevalence of chronic complications in Type 2 diabetes
Author(s) -
Costa L. A.,
Canani L. H.,
Lisbôa H. R. K.,
Tres G. S.,
Gross J. L.
Publication year - 2004
Publication title -
diabetic medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.474
H-Index - 145
eISSN - 1464-5491
pISSN - 0742-3071
DOI - 10.1111/j.1464-5491.2004.01124.x
Subject(s) - medicine , metabolic syndrome , microalbuminuria , retinopathy , diabetes mellitus , type 2 diabetes , diabetic retinopathy , type 2 diabetes mellitus , nephropathy , coronary artery disease , peripheral neuropathy , gastroenterology , obesity , vascular disease , disease , endocrinology
Aims To investigate the association of features of the metabolic syndrome with the prevalence of chronic complications. Methods A cross‐sectional study was conducted with 548 patients with Type 2 diabetes mellitus (DM). Metabolic syndrome was diagnosed in the presence of at least two of the following: hypertension, dyslipidaemia, obesity, and microalbuminuria. Results Patients with the metabolic syndrome (85%) had a higher prevalence of peripheral vascular disease (PVD) (35% vs. 18%), retinopathy (44% vs. 20%), distal sensory neuropathy (DSN) (44% vs. 24%), micro‐ and macroalbuminuria (38% vs. 28%) and coronary artery disease (CAD) (53% vs. 36%). The more metabolic syndrome features (none/one, two, three or four), the higher the proportion of diabetes complications: PVD 18%, 31%, 37% and 38%; stroke 1.0%, 4.5%, 5.9% and 11.3%; retinopathy 20%, 38%, 42% and 64%; DSN 24%, 32%, 49% and 57%; micro‐ and macroalbuminuria 28%, 36% and 41%; and CAD 36%, 44%, 52% and 60% ( P < 0.05). Conclusions The metabolic syndrome and the aggregation of its components were significantly associated with macro‐ and microvascular complications in Type 2 DM patients.